Eli Lilly (LLY) Tax Rate Growth (5y) (2014 - 2026)
Eli Lilly (LLY) Tax Rate Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn |
| 10 | Novartis Ag | 112.59 Bn | 111.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 823.00 |
| Dec 31, 2025 | 543.00 |
| Sep 30, 2025 | 689.00 |
| Jun 30, 2025 | 237.00 |
| Mar 31, 2025 | 687.00 |
| Dec 31, 2024 | 241.00 |
| Sep 30, 2024 | 2,811.00 |
| Jun 30, 2024 | 618.00 |
| Mar 31, 2024 | -1,169.00 |
| Dec 31, 2023 | 3,309.00 |
| Sep 30, 2023 | 9,498.00 |
| Jun 30, 2023 | -63,980.00 |
| Mar 31, 2023 | -245.00 |
| Dec 31, 2022 | -48,822.00 |
| Sep 30, 2022 | 118.00 |
| Jun 30, 2022 | -734.00 |
| Mar 31, 2022 | -27,371.00 |
| Dec 31, 2021 | -729.00 |
| Sep 30, 2021 | -899.00 |
| Jun 30, 2021 | -806.00 |